Vulvovaginal Atrophy
| GEHC-SHSWH-DRSE-OT9211 | |
| Clinical Training | |
| GE HealthCare | |
Add to Wish List
Login To Shop
Please select date
Second Opinion Approval Needed
Enter your approval number and submit to add item(s) to cart.
Approval Number
Please enter approval number
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without the
approval number, GE will contact you before your order
can be confirmed for shipment.
Second Opinion Approval Needed
Select your approver's name and submit to add item(s) to your cart
Approver Name
Please Select Approver Name
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without
selecting an approver, GE will contact you before your order
can be confirmed for shipment.
Product Overview
Vulvovaginal atrophy (VA) refers to a constellation of physiologic changes in the skin and mucous membranes of the vulva and vagina in response to hypoestrogenic state, most often caused by menopause. Several professional societies suggest that this condition can be referred to as the genitourinary syndrome of menopause (GSM). Vulvovaginal atrophy is also known as vaginal atrophy, urogenital atrophy, and atrophic vaginitis. After completing this course, you should be able to: • Identify women at high risk of symptomatic vulvovaginal atrophy, especially subsets who experience early menopause or have induced menopause from surgery, radiation therapy (RT), or a therapeutic or chemotherapeutic intervention • Recognize the spectrum of symptoms related to vulvovaginal atrophy and its medical implications, such as recurrent urinary tract infections, in both sexually active and non-sexually active women • Diagnose vulvovaginal atrophy based on physical exam findings and appropriate clinical evaluations • Describe diverse treatment modalities and their mode of application, risks, benefits, and side effects • Recommend treatment for each woman with symptomatic vulvovaginal atrophy, based on her needs, medical history, and personal preferences
